Report Content
Chapter 1 Methodology
1.1 Industry coverage
1.2 Market scope & definitions
1.3 Base estimates & working
1.3.1 Data collection
1.4 Forecast parameters
1.5 COVID-19 impact analysis at country level
1.6 Data validation
1.7 Data sources
1.7.1 Primary
1.7.2 Secondary
1.7.2.1 Paid sources
1.7.2.2 Unpaid sources
Chapter 2 Executive Summary
2.1 Clinical Nutrition industry 3600 synopsis, 2018 - 2032
2.1.1 Business trends
2.1.2 Product trends
2.1.3 Consumer trends
2.1.4 Application trends
2.1.5 Distribution channel trends
2.1.6 Dosage formulation trends
2.1.7 Regional trends
Chapter 3 Clinical Nutrition Industry Insights
3.1 Industry landscape, 2018 - 2032 (USD Million)
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Increasing metabolic disorders and other chronic diseases
3.2.1.2 High junk food consumption leading to malnourishment
3.2.1.3 Rising geriatric population worldwide
3.2.1.4 Increasing incidence of pre-mature birth & birth rate
3.2.1.5 Increasing adoption of home healthcare
3.2.2 Industry pitfalls & challenges
3.2.2.1 Stringent government regulations
3.2.2.2 Lack of awareness
3.3 Growth potential analysis
3.3.1 By product
3.3.2 By consumer
3.3.3 By application
3.3.4 By distribution channel
3.3.5 By dosage formulation
3.4 COVID-19 impact analysis
3.5 Key market trends
3.6 Technology landscape
3.7 Supply chain analysis for clinical nutrition
3.8 Regulatory landscape
3.9 Reimbursement scenario
3.10 Porter’s analysis
3.11 PESTEL analysis
Chapter 4 Competitive Landscape, 2021
4.1 Introduction
4.2 Company matrix analysis, 2021
4.3 Competitive analysis of major market players
4.4 Competitive Positioning matrix
4.5 Strategy dashboard, 2021
Chapter 5 Clinical Nutrition Market, By Product
5.1 Key segment trends
5.2 Infant nutrition
5.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.2.2 Milk based
5.2.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.2.3 Soy based
5.2.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.2.4 Organic formulas
5.2.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.2.5 Others
5.2.5.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.3 Enteral nutrition
5.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.3.2 Standard composition
5.3.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.3.3 Disease specific composition
5.3.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.4 Parenteral nutrition
5.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.4.2 Amino acids
5.4.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.4.3 Fats
5.4.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.4.4 Carbohydrates
5.4.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.4.5 Others
5.4.5.1 Market estimates and forecast, 2018 - 2032 (USD Million)
Chapter 6 Clinical Nutrition Market, By Consumer
6.1 Key segment trends
6.2 Pediatric
6.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
6.3 Adult
6.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
Chapter 7 Clinical Nutrition Market, By Application
7.1 Key segment trends
7.2 Cancer
7.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
7.3 Metabolic disorders
7.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
7.4 Neurological diseases
7.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
7.5 Gastrointestinal disorders
7.5.1 Market estimates and forecast, 2018 - 2032 (USD Million)
7.6 Others
7.6.1 Market estimates and forecast, 2018 - 2032 (USD Million)
Chapter 8 Clinical Nutrition Market, By Distribution Channel
8.1 Key segment trends
8.2 Retail stores
8.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
8.3 Pharmacies & drug stores
8.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
8.4 Online channels
8.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
8.5 Others
8.5.1 Market estimates and forecast, 2018 - 2032 (USD Million)
Chapter 9 Clinical Nutrition Market, By Dosage Formulation
9.1 Key segment trends
9.2 Powder
9.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
9.3 Liquid
9.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
9.4 Solid
9.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
Chapter 10 Clinical Nutrition Market, By Region
10.1 Key regional trends
10.2 North America
10.2.1 U.S.
10.2.2 Canada
10.3 Europe
10.3.1 Germany
10.3.2 UK
10.3.3 France
10.3.4 Spain
10.3.5 Italy
10.3.6 Poland
10.3.7 Switzerland
10.3.8 Sweden
10.3.9 Netherlands
10.4 Asia Pacific
10.4.1 China
10.4.2 Japan
10.4.3 India
10.4.4 Australia
10.4.5 South Korea
10.4.6 Indonesia
10.4.7 Thailand
10.4.8 Vietnam
10.5 Latin America
10.5.1 Brazil
10.5.2 Mexico
10.5.3 Argentina
10.5.4 Chile
10.5.5 Columbia
10.5.6 Peru
10.6 Middle East & Africa
10.6.1 South Africa
10.6.2 Saudi Arabia
10.6.3 UAE
10.6.4 Iran
10.6.5 Egypt
10.6.6 Israel
Chapter 11 Company Profiles
11.1 Abbott Laboratories (Abbott Nutrition)
11.2 B Braun Melsungen AG
11.3 Baxter International Inc.
11.4 Fresenius Kabi
11.5 Mead Johnson (Reckitt Benckiser)
11.6 Nestle Health Science
11.7 Perrigo
11.8 Pfizer, Inc.
11.9 Danone
11.10 Hero Nutritionals Inc.
11.11 AYMES International Ltd
11.12 Medifood International Ltd
11.13 Royal DSM
11.14 BASF SE
11.15 Aculife Healthcare Pvt Ltd
11.16 Amanta Healthcare
11.17 Hormel Foods Corporation
11.18 Meiji Holdings Co Ltd
11.19 Grifols SA
